A computational atlas of the hippocampal formation using ex vivo, ultra-high resolution MRI: Application to adaptive segmentation of in vivo MRI
Harvard University · Basque Center on Cognition, Brain and Language · +9 more institutions
Abstract
Automated analysis of MRI data of the subregions of the hippocampus requires computational atlases built at a higher resolution than those that are typically used in current neuroimaging studies. Here we describe the construction of a statistical atlas of the hippocampal formation at the subregion level using ultra-high resolution, ex vivo MRI. Fifteen autopsy samples were scanned at 0.13 mm isotropic resolution (on average) using customized hardware. The images were manually segmented into 13 different hippocampal substructures using a protocol specifically designed for this study; precise delineations were made possible by the extraordinary resolution of the scans. In addition to the subregions, manual…
Citation impact
- FWCI
- 31.30
- Percentile
- 100%
- References
- 87
Authors
12- JEJuan Eugenio IglesiasCorresponding
Harvard University, Basque Center on Cognition, Brain and Language, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital
- JCJean C. Augustinack
Athinoula A. Martinos Center for Biomedical Imaging, Harvard University, Massachusetts General Hospital
- KNKhoa Nguyen
Harvard University, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital
- CMChristopher M. Player
Harvard University, Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital
- APAllison Player
Massachusetts General Hospital, Harvard University, Athinoula A. Martinos Center for Biomedical Imaging
Topics & keywords
- Segmentation
- Computer science
- Atlas (anatomy)
- Hippocampal formation
- Artificial intelligence
- Neuroimaging
- Pattern recognition (psychology)
- Magnetic resonance imaging
- Reduced inequalities
Funding
- UDU.S. Department of DefenseAwards: U01 AG024904, W81XWH, W81XWH-12-2-, W81XWH-12-2-0012, AG024904
- FFFoundation for the National Institutes of HealthAwards: W81XWH-12-2-0012, Grant U01 AG024904, AG024904, U01 AG024904, P41EB015896
- EMEllison Medical FoundationAward: 5R01AG008122-22
- AAAlzheimer's AssociationAwards: AG010129, U01 AG024904, ADNI 2-12-233036, W81XWH-12-2-0012
- BSBristol-Myers SquibbAwards: U01 AG024904, AG024904, W81XWH-12-2-0012
- ELEli Lilly and CompanyAwards: U01 AG024904, AG024904, W81XWH-12-2-0012
- PPfizerAwards: AG024904, W81XWH-12-2-0012, U01 AG024904
- BBiogenAwards: W81XWH-12-2-0012, U01 AG024904, AG024904
- UOUniversity of Southern CaliforniaAwards: W81XWH-12-2-0012, U01 AG024904
- FHF. Hoffmann-La RocheAwards: W81XWH-12-2-0012, AG024904, U01 AG024904
- MMedpaceAward: U01 AG024904
- MSMeso Scale DiagnosticsAwards: U01 AG024904, AG024904, W81XWH-12-2-0012
- SSynarcAward: U01 AG024904
- ADAlzheimer's Disease Neuroimaging InitiativeAwards: AG024904, ADNI 2-12-233036, W81XWH-12-2-, W81XWH-12-2-0012, 2-12-233036, Department of Defense award number W81XWH-12-2-0012, U01 AG024904
- BBioClinicaAwards: ADNI 2, U01 AG024904, W81XWH-12-2-0012, AG024904
- NPNovartis Pharmaceuticals CorporationAwards: W81XWH-12-2-0012, U01 AG024904, AG024904
- NCNorthern California Institute for Research and EducationAwards: U01 AG024904, W81XWH-12-2-0012
- EEisaiAwards: W81XWH-12-2-0012, U01 AG024904, AG024904
- SServierAwards: AG024904, W81XWH-12-2-0012, U01 AG024904
- IIXICOAwards: AG024904, W81XWH-12-2-0012, U01 AG024904
- DFDiputación Foral de Gipuzkoa
- NINational Institutes of HealthAwards: P41EB015896, AG024904, P30AG13846, 1S10RR023401, P30-AG010129, grants P30-AG010129, U01 AG024904, K01-AG030514, U24 RR021382, W81XWH, BIRN002, Grant U01 AG024904, 1S10RR019307, R01EB006758, AG022381, W81XWH-12-2-0012, 5R01AG008122, AG010129, 1S10RR023043, AG030514, R01NS083534
- GGenentechAwards: W81XWH-12-2-0012, AG024904, U01 AG024904
- UOUniversity of California, San Diego
- CICanadian Institutes of Health ResearchAwards: U01 AG024904, W81XWH-12-2-0012
- NINational Institute on AgingAwards: 1S10RR023043, U01 AG024904, R01NS083534, P41EB015896, R01AG1649, 1S10RR019307, U24 RR021382, W81XWH-12-2-0012, AG010129, AG022381, 5R01AG008122-22, 5U01-MH093765, AG024904, 1S10RR023401, R01EB006758, K01AG028521, P30AG13846, 5R01AG008122
- NCNational Center for Complementary and Alternative MedicineAward: RC1 AT005728-01
- NINational Institute of Neurological Disorders and StrokeAwards: 1R01NS070963, R01NS083534, R01 NS052585-01, 1R21NS072652-01
- NINational Institute of Biomedical Imaging and BioengineeringAwards: 1S10RR023401, P41EB015896, 5R01AG008122, 1S10RR023043, R01EB013565, W81XWH-12-2-0012, U24 RR021382, R01NS083534, 5U01-MH093765, U01 AG024904, R01EB006758, 1S10RR019307, AG024904
- NCNational Center for Research ResourcesAwards: BIRN002, U24 RR021382, P41EB015896, BIRN002, U01 AG024904, 1S10RR019307, 1S10RR023043, R01EB013565, U24 RR021382, 1S10RR023401
- NBNIH Blueprint for Neuroscience ResearchAwards: P41EB015896, 5U01-MH093765, R01EB006758, R01NS083534, 1S10RR023401, 5R01AG008122, 1S10RR023043, 1S10RR019307